{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:24:14Z","timestamp":1779380654990,"version":"3.53.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vaccine.2007.02.051","type":"journal-article","created":{"date-parts":[[2007,3,16]],"date-time":"2007-03-16T11:01:31Z","timestamp":1174042891000},"page":"4020-4028","source":"Crossref","is-referenced-by-count":20,"title":["Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2"],"prefix":"10.1016","volume":"25","author":[{"given":"Sonika","family":"Patial","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.K.","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.02.051_bib1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2007.02.051_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.1995.tb44727.x","article-title":"Overview of DNA vaccines","volume":"772","author":"Liu","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2007.02.051_bib3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2796.2003.01140.x","article-title":"DNA vaccines: a review","volume":"253","author":"Liu","year":"2003","journal-title":"J Int Med"},{"key":"10.1016\/j.vaccine.2007.02.051_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/viro.1995.1289","article-title":"Immune responses to nucleic acid vaccines to rabies virus","volume":"209","author":"Xiang","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.02.051_bib5","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0264-410X(96)00281-2","article-title":"Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection","volume":"15","author":"Ray","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.051_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0264-410X(97)00204-1","article-title":"DNA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses","volume":"16","author":"Bahloul","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.051_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm0898-949","article-title":"DNA immunization protects non-human primates against rabies virus","volume":"4","author":"Lodmell","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2007.02.051_bib8","first-page":"1012","article-title":"Evaluation of the protective efficacy of a rabies DNA vaccine in mice using an intracerebral challenge model","volume":"76","author":"Biswas","year":"1999","journal-title":"Curr Sci"},{"key":"10.1016\/j.vaccine.2007.02.051_bib9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0264-410X(98)00328-4","article-title":"Immunization of dogs and cats with a DNA vaccine against rabies virus","volume":"17","author":"Osorio","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.051_bib10","first-page":"47","article-title":"Immunization of dogs with a DNA vaccine induces protection against rabies virus","volume":"18","author":"Perrin","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.051_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0264-410X(01)00392-9","article-title":"One-time gene gun or intra-muscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination","volume":"20","author":"Lodmell","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.051_bib12","first-page":"58","article-title":"Immunogenicity of a plasmid DNA vaccine encoding glycoprotein gene of rabies virus CVS in mice and dogs","volume":"7","author":"Gupta","year":"2005","journal-title":"J Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2007.02.051_bib13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.vaccine.2005.09.016","article-title":"Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions","volume":"24","author":"Bahloul","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.051_bib14","first-page":"87","article-title":"A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection","volume":"50","author":"Gupta","year":"2006","journal-title":"Acta Virol"},{"key":"10.1016\/j.vaccine.2007.02.051_bib15","series-title":"Lyssaviruses","first-page":"1","article-title":"Rationale and prospects for rabies elimination in developing countries","author":"Meslin","year":"1994"},{"key":"10.1016\/j.vaccine.2007.02.051_bib16","series-title":"Fields virology","first-page":"1137","article-title":"Rhabdoviruses","author":"Dietzschold","year":"1996"},{"key":"10.1016\/j.vaccine.2007.02.051_bib17","first-page":"37","article-title":"New enteric viruses in the dogs","volume":"25","author":"Carmichael","year":"1981","journal-title":"Adv Vet Sci Compend Med"},{"key":"10.1016\/j.vaccine.2007.02.051_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0065-3527(08)60867-2","article-title":"Emergence, natural history and variation of canine, mink and feline parvoviruses","volume":"38","author":"Parrish","year":"1990","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2007.02.051_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0264-410X(97)00239-9","article-title":"Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus","volume":"16","author":"Jiang","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.051_bib20","first-page":"778","article-title":"Cloning of canine parvovirus VP2 gene and its use as DNA vaccine in dogs","volume":"88","author":"Gupta","year":"2005","journal-title":"Curr Sci"},{"key":"10.1016\/j.vaccine.2007.02.051_bib21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0042-6822(03)00325-8","article-title":"Immunization with a dicistronic plasmid expressing a truncated form of bovine herpes-1 glycoprotein D and the amino-terminal subunit of glycoprotein B results in reduced gB-specific immune responses","volume":"313","author":"Manoj","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2007.02.051_bib22","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1172\/JCI200421323","article-title":"Poliovirus tropism and attenuation are determined after internal ribosome entry","volume":"113","author":"Kauder","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2007.02.051_bib23","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1128\/MCB.11.12.5848","article-title":"The encephalomyocarditis virus internal ribosomal entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos","volume":"11","author":"Ghattas","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2007.02.051_bib24","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1128\/IAI.72.10.5565-5573.2004","article-title":"A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4\/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria","volume":"72","author":"Rainczuk","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2007.02.051_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000092487","article-title":"Co-expression of interleukin-2 by a bicistronic plasmid increases the efficacy of DNA immunization to prevent influenza virus infections","volume":"49","author":"Henke","year":"2006","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2007.02.051_bib26","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1101\/gad.891101","article-title":"Internal ribosome entry sites in eukaryotic mRNA molecules","volume":"15","author":"Hellen","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.vaccine.2007.02.051_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/bbrc.1996.1795","article-title":"IRES bicistronic expression vectors for efficient creation of stable mammalian cell lines","volume":"229","author":"Gurtu","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2007.02.051_bib28","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4049\/jimmunol.168.2.562","article-title":"Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF","volume":"168","author":"Barouch","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.02.051_bib29","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1073\/pnas.152313899","article-title":"A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice","volume":"99","author":"Agwale","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.02.051_bib30","series-title":"Laboratory techniques in rabies","first-page":"360","article-title":"The NIH test for potency","author":"Wilbur","year":"1996"},{"key":"10.1016\/j.vaccine.2007.02.051_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetmic.2005.04.007","article-title":"Immunogenic and antigenic properties of recombinant soluble glycoprotein of rabies virus","volume":"108","author":"Gupta","year":"2005","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2007.02.051_bib32","series-title":"Laboratory techniques in rabies","first-page":"181","article-title":"A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody","author":"Smith","year":"1996"},{"key":"10.1016\/j.vaccine.2007.02.051_bib33","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1073\/pnas.95.6.3152","article-title":"Rabies virus quasispecies: implications for pathogenesis","volume":"95","author":"Morimoto","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2007.02.051_bib34","series-title":"WHO expert consultation on rabies","author":"WHO","year":"2004"},{"key":"10.1016\/j.vaccine.2007.02.051_bib35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/356152a0","article-title":"Genetic immunization is a simple method for eliciting an immune response","volume":"356","author":"Tang","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2007.02.051_bib36","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1128\/JVI.67.9.5664-5667.1993","article-title":"Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA","volume":"67","author":"Cox","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2007.02.051_bib37","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2007.02.051_bib38","first-page":"2782","article-title":"Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients","volume":"8","author":"Conry","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.vaccine.2007.02.051_bib39","first-page":"123","article-title":"Cloning of rabies virus glycoprotein gene in a mammalian expression vector and immunogenicity of the recombinant plasmid DNA","volume":"23","author":"Rai","year":"2002","journal-title":"Indian J Comp Microbiol Immunol Inf Dis"},{"key":"10.1016\/j.vaccine.2007.02.051_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0264-410X(03)00568-1","article-title":"Post-exposure therapy in mice against experimental rabies: a single injection of DNA vaccine is as effective as five injections of cell culture-derived vaccine","volume":"22","author":"Bahloul","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.051_bib41","doi-asserted-by":"crossref","first-page":"715","DOI":"10.12935\/jvma1951.42.715","article-title":"Immunogenicity of an inactivated vaccine prepared from the cell culture-adapted RC-HL strain of rabies virus","volume":"42","author":"Ishikawa","year":"1989","journal-title":"J Jpn Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2007.02.051_bib42","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/mthe.2000.0050","article-title":"IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector","volume":"1","author":"Mizuguchi","year":"2000","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2007.02.051_bib43","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1016\/S0264-410X(03)00297-4","article-title":"Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody","volume":"21","author":"Lodmell","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.051_bib44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2005.08.003","article-title":"One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus","volume":"24","author":"Lodmell","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.051_bib45","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.vaccine.2004.10.018","article-title":"Impact of plasmid supercoiling on the efficacy of a rabies DNA vaccine to protect cats","volume":"23","author":"Cupillardb","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.051_bib46","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0264-410X(01)00392-9","article-title":"Hanlon One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination","volume":"20","author":"Lodmell","year":"2002","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T21:58:50Z","timestamp":1587419930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07002277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":46,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0264410X07002277"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.02.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}